Ian Gillespie is Chief Executive of Vanguard Healthcare, a role he assumed following the management buy-out of Vanguard from Nuffield Health in 2009. Before the MBO, Ian held the position of Managing Director of Vanguard – a post that he filled after joining Nuffield Hospitals in September 2007 as Director of Primary Care.
Prior to his time at Vanguard and Nuffield, Ian ran a variety of businesses in the UK and the US, latterly as Vice President Medical of the BOC Group. He has championed innovation throughout his career and has been on the leading edge of groundbreaking healthcare developments since 1995 when he worked on, among other projects, the creation of a unique lifesaving therapy for persistent pulmonary hypertension in newborns.
"Novartis are delighted to continue to support the Future Health Summit. The event is always high quality from its organisation to its speakers, and is a must attend event for anyone with an interest in improving healthcare and outcomes for patients"Ian Addie, Patient Access Head, Novartis Ireland Ltd
"‘Irish Heart would like to extend our thanks for having our mobile health unit attend the Future Health Summit. The mobile health unit was extremely well received and there was over 130 blood pressure checks taken over the two days,. The event was fantastic."Emma Carter ,Mobile Health Unit Manager ,Irish Heart
"‘I have spoken at and attended this event for the last six years and in a short space of time the Future Health Summit has become an annual meeting place for progressive healthcare leaders who want to drive change and improve healthcare delivery. "Mr. Bill Maher, Chief Executive, Bon Secours Health System
"“This Conference is another one of Ireland’s global contributions. The Future Health Summit is required attendance for all who wish to engage in a stimulating interchange on the future of healthcare – globally and domestically""Michael Dowling , Chief Executive Officer of Northwell Health